Charleson is a PhD candidate at Vanderbilt University's biomedical engineering program. The culmination of Charleson’s previous studies in low analyte detection of cancer biomarkers and the fabrication of novel nanoparticles with his current studies regarding the treatment of multi-drug resistant bacteria, lead him to devise the technology behind BioNanovations’ diagnostic strategy.

Todd is well suited due to his experience in the fields of development and application of nanotechnology to biology and medicine and his current appointment as Chair and Professor of Biomedical Engineering at Vanderbilt University and Chair of the Council of Chairs of the Biomedical Engineering Society. These appointments give him great breadth and reach as an internationally recognized center of scientific influence.

Andre is a graduate of Vanderbilt University earning a Bachelor of Engineering degree in biomedical engineering.